Pirtobrutinib after a Covalent BTK Inhibitor in Chronic Lymphocytic Leukemia

Mato, AR; Woyach, JA; Brown, JR; Ghia, P; Patel, K; Eyre, TA; Munir, T; Lech-Maranda, E; Lamanna, N; Tam, CS; Shah, NN; Coombs, CC; Ujjani, CS; Fakhri, B; Cheah, CY; Patel, MR; Alencar, AJ; Cohen, JB; Gerson, JN; Flinn, IW; Ma, S; Jagadeesh, D; Rhodes, JM; Hernandez-Ilizaliturri, F; Zinzani, PL; Seymour, JF; Balbas, M; Nair, B; Abada, P; Wang, CX; Ruppert, AS; Wang, D; Tsai, DE; Wierda, WG; Jurczak, W

Woyach, JA (通讯作者)，Ohio Univ, Ctr Comprehens Canc, 460 W 10th Ave, Columbus, OH 43210 USA.

NEW ENGLAND JOURNAL OF MEDICINE, 2023; 389 (1): 33

Abstract

BACKGROUND Patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) have poor outcomes after the failure of covalent Bruto......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索